[go: up one dir, main page]

DK1024795T3 - Formuleringer med reguleret frigivelse - Google Patents

Formuleringer med reguleret frigivelse

Info

Publication number
DK1024795T3
DK1024795T3 DK98950189T DK98950189T DK1024795T3 DK 1024795 T3 DK1024795 T3 DK 1024795T3 DK 98950189 T DK98950189 T DK 98950189T DK 98950189 T DK98950189 T DK 98950189T DK 1024795 T3 DK1024795 T3 DK 1024795T3
Authority
DK
Denmark
Prior art keywords
film
composition
forming
controlled release
water
Prior art date
Application number
DK98950189T
Other languages
English (en)
Inventor
John Michael Newton
Lee Fung Siew
Original Assignee
Btg Int Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Btg Int Ltd filed Critical Btg Int Ltd
Application granted granted Critical
Publication of DK1024795T3 publication Critical patent/DK1024795T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Manufacture Of Macromolecular Shaped Articles (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
DK98950189T 1997-10-23 1998-10-23 Formuleringer med reguleret frigivelse DK1024795T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9722426.5A GB9722426D0 (en) 1997-10-23 1997-10-23 Controlled release formulations
PCT/GB1998/003178 WO1999021536A1 (en) 1997-10-23 1998-10-23 Controlled release formulations

Publications (1)

Publication Number Publication Date
DK1024795T3 true DK1024795T3 (da) 2002-12-02

Family

ID=10820995

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98950189T DK1024795T3 (da) 1997-10-23 1998-10-23 Formuleringer med reguleret frigivelse

Country Status (10)

Country Link
US (1) US6534549B1 (da)
EP (1) EP1024795B1 (da)
JP (2) JP2001520986A (da)
AT (1) ATE221773T1 (da)
CA (1) CA2302585C (da)
DE (1) DE69807104T2 (da)
DK (1) DK1024795T3 (da)
ES (1) ES2178268T3 (da)
GB (1) GB9722426D0 (da)
WO (1) WO1999021536A1 (da)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6929884B2 (en) * 2001-04-19 2005-08-16 Zinc Matrix Power, Inc. Method for manufacture of films containing insoluble solids embedded in cellulose-based films
AR036797A1 (es) 2001-10-15 2004-10-06 Ferring Bv Un metodo para preparar una composicion farmaceutica que comprende acido 5-aminosalicilico para utilizar en el tratamiento de colitis ulcerosa y enfermedades de crohn
GB0203421D0 (en) * 2002-02-13 2002-04-03 Alizyme Therapeutics Ltd Composition
US20070042143A1 (en) 2003-04-23 2007-02-22 Ferring B.V. Sachet for a pharmaceutical composition
FR2862654B1 (fr) 2003-11-20 2006-02-10 Roquette Freres Composition amylacee filmogene
EP1547601A1 (en) 2003-12-23 2005-06-29 Ferring B.V. Coating method
WO2005097061A1 (en) * 2004-04-01 2005-10-20 Procyte Corporation Encapsulated peptide copper complexes and compositions and methods related thereto
US8048919B2 (en) * 2004-06-28 2011-11-01 Archer Daniels Midland Company Use of ethyl lactate as an excipient for pharmaceutical compositions
TW200700107A (en) * 2005-03-16 2007-01-01 Procyte Corp Methods and compositions for preventing and treating aging or photodamaged skin
US20090017110A1 (en) * 2005-05-31 2009-01-15 Capricorn Pharma Inc. Modified release formulations of anti-irritability drugs
GB0607534D0 (en) * 2006-04-13 2006-05-24 Univ London Pharmacy Colonic drug delivery formulation
JP2009544684A (ja) * 2006-07-27 2009-12-17 ユニヴァーシティ・オヴ・サンダーランド デンプンを含むコーティング組成物
US20090036414A1 (en) * 2007-08-02 2009-02-05 Mutual Pharmaceutical Company, Inc. Mesalamine Formulations
EP2272119B1 (en) 2008-03-27 2014-04-23 ZPower, LLC Electrode separator
GB0808537D0 (en) * 2008-05-12 2008-06-18 Archimedes Dev Ltd Compositions
FR2934467B1 (fr) * 2008-07-31 2014-08-22 Roquette Freres Forme solide pelliculee et procede de pelliculage a temperature ambiante.
ES2425762T3 (es) 2008-10-27 2013-10-17 Roquette Freres Polímero insoluble en agua: revestimientos de película a base de derivados de almidón modificado para la liberación dirigida al colon
DE102008059206A1 (de) 2008-11-27 2010-06-10 Bayer Schering Pharma Aktiengesellschaft Pharmazeutische Darreichungsform enthaltend Nifedipin oder Nisoldipin und einen Angiotensin-II Antagonisten und/oder ein Diuretikum
US9314444B2 (en) 2009-01-12 2016-04-19 Biokier, Inc. Composition and method for treatment of NASH
US9006288B2 (en) 2009-01-12 2015-04-14 Biokier, Inc. Composition and method for treatment of diabetes
HRP20170886T1 (hr) 2009-01-12 2017-09-08 Biokier Inc. Smjesa i metoda za liječenje dijabetesa
CA2774616A1 (en) 2009-09-23 2011-03-31 Biokier, Inc. Composition and method for treatment of diabetes
UA108360C2 (uk) 2009-10-01 2015-04-27 Тверда фармацевтична композиція кортикостероїду, що розпадається у ротовій порожнині
US9963368B2 (en) 2010-11-15 2018-05-08 Archer Daniels Midland Company Microemulsions and uses thereof in dispersing catalysts
PL2659881T3 (pl) 2012-04-30 2018-05-30 Tillotts Pharma Ag Formulacja leku o opóźnionym uwalnianiu
US20140271931A1 (en) * 2013-03-12 2014-09-18 Perosphere Inc. Anti-Acne Topical Films
WO2015034678A2 (en) 2013-09-06 2015-03-12 Aptalis Pharmatech, Inc. Corticosteroid containing orally disintegrating tablet compositions for eosinophilic esophagitis
JP6273356B2 (ja) 2013-10-29 2018-01-31 ティロッツ・ファルマ・アクチエンゲゼルシャフトＴｉｌｌｏｔｔｓ Ｐｈａｒｍａ Ａｇ 遅延放出性薬物製剤
EP3662898A1 (en) 2018-12-07 2020-06-10 Tillotts Pharma AG Solid composition comprising mesalazine
EP3662900A1 (en) 2018-12-07 2020-06-10 Tillotts Pharma AG Colonic drug delivery formulation
EP3662901B1 (en) 2018-12-07 2025-01-01 Tillotts Pharma AG Delayed release drug formulation comprising an outerlayer with an enzymatically degradable polymer, its composition and its method of manufacturing
ES2994844T3 (en) 2018-12-07 2025-02-03 Tillotts Pharma Ag Colonic drug delivery formulation
US11896719B2 (en) 2022-01-24 2024-02-13 Calliditas Therapeutics Ab Pharmaceutical compositions

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8926639D0 (en) * 1989-11-24 1990-01-17 Agricultural & Food Res Delayed release formulations

Also Published As

Publication number Publication date
ES2178268T3 (es) 2002-12-16
ATE221773T1 (de) 2002-08-15
DE69807104D1 (de) 2002-09-12
CA2302585C (en) 2007-09-25
EP1024795A1 (en) 2000-08-09
WO1999021536A1 (en) 1999-05-06
GB9722426D0 (en) 1997-12-24
US6534549B1 (en) 2003-03-18
EP1024795B1 (en) 2002-08-07
CA2302585A1 (en) 1999-05-06
DE69807104T2 (de) 2002-12-05
JP2001520986A (ja) 2001-11-06
JP2010270335A (ja) 2010-12-02

Similar Documents

Publication Publication Date Title
DK1024795T3 (da) Formuleringer med reguleret frigivelse
FI962111A0 (fi) Mikrokapseloidut 3-piperidinyyli-substituoidut 1,2-bentsisoksatsolit ja 1,2-bentsisotiatsolit
DE69832621D1 (de) Pharmazeutische formulierungen mit kontrollierter freigabe von wirkstoffen
ATE161174T1 (de) Feste zubereitung mit hoher freisetzung, ihre herstellung und verwendung
ES2173096T3 (es) Composicion farmaceutica peletizada.
IS5669A (is) Lyfjasamsetning sem mögulegt er að hleypa
NO175240C (no) Fremgangsmåte for fremstilling av et langsomt frigivende farmasöytisk preparat som omfatter sekundære granuler
PT1017367E (pt) Metodos para fabricar preparacoes de libertacao controlada baseadas em polimeros
MY106628A (en) Estrogen-containing active substance plaster
ATE356614T1 (de) Veränderung der wirkstoffladung in multivesikulären liposomen
DK0531611T3 (da) Matrix med reguleret frigivelse til lægemidler
SE8603247D0 (sv) Farmaceutiskt granulat
NO964410D0 (no) Matriks-pelleter med langsom frigiving, samt fremstilling av disse
KR900002769A (ko) 장시간 작용하는 나트륨 디클로페낙의 제제
AU3483497A (en) Solid solution of an antifungal agent with enhanced bioavailability
YU49113B (sh) Postupak za dobijanje klavulanat soli
MX9803829A (es) Esteres de acido carboxilico aromatico, la produccion de los mismos y el uso de los mismos como medicamentos.
JPS5312978A (en) Isolation of low-molecular weight polymers
TR199900013T2 (xx) Yeni bile�ikler.
JPS57142913A (en) Donor of physiologically active substance
ATE266646T1 (de) Phenanthryl-piperazinyl-dicarbonsäure als selective nmda-rezeptor modulierende mittel
CA2020590A1 (en) Solid pharmaceutical composition containing a core and an outer layer